Browse result page of THPdb

The total number entries retrieved from this search are 10

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1025	ThPPIDTh1004	NameDenileukin diftitox	Peptide SequenceMGADDVVDSSKSFVMENFSS Full view	Length255	Functional ClassificationIIb	DiseaseCancer	BrandOntak	CompanySeragen Inc	Physical AppearanceSterile, white, preservative-free, lyophilized powder.	Route of AdministartionIntravenous(IV) administration	CategoryAntineoplastic Agents	TargetInterleukin-2 receptor subunit alpha,Interleukin-2 receptor subunit beta,Cytokine receptor common subunit gamma
ID1406	ThPPIDTh1066	NameIbritumomab	Peptide SequenceHeavy Chain: QAYLQQS Full view	Length652	Functional ClassificationIIb	DiseaseCancer	BrandZevalin	CompanySpectrum Pharmaceuticals	Physical AppearanceClear, colorless, sterile, pyrogen-free, preservative-free solution that may contain translucent particles.	Route of AdministartionIntravenous infusion	CategoryN.A.	TargetDigoxin
ID1412	ThPPIDTh1068	NameTositumomab	Peptide SequenceHeavy Chain 1: QAYLQ Full view	Length1351	Functional ClassificationIIb	DiseaseCancer	BrandBexxar	CompanyGalaxo Smith Kline	Physical AppearanceSterile, pyrogen-free, clear to opalescent, colorless to slightly yellow, preservative-free solutionÂÂÂ	Route of AdministartionIntravenous(IV) administration	CategoryN.A.	TargetBacterial outer membrane,Lipoteichoic acid synthesis
ID1470	ThPPIDTh1092	NameArcitumomab	Peptide SequenceHeavy chain 1EVKLVES Full view	Length1310	Functional ClassificationIIb	DiseaseCancer	BrandCEA-Scan	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryDiagnostic Agents	TargetVascular endothelial growth factor A,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Carcinoembryonic antigen-related cell adhesion molecule 1
ID1583	ThPPIDTh1125	NameGolimumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIb	DiseaseImmunological	BrandSimponi Injection	CompanyN.A.	Physical AppearanceClear to slightly opalescent, colorless to light yellow solution	Route of AdministartionSubcutaneous injection	CategoryAntipsoriatic Agents and Monoclonal antibodies and TNF inhibitor	TargetTumor necrosis factor
ID1584	ThPPIDTh1125	NameGolimumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIb	DiseaseImmunological	BrandSimponi Injection	CompanyN.A.	Physical AppearanceSterile concentrated solution of the golimumab antibody	Route of AdministartionIntravenous infusion	CategoryAntipsoriatic Agents and Monoclonal antibodies and TNF inhibitor	TargetTumor necrosis factor
ID1604	ThPPIDTh1130	NameBrentuximab Vedotin	Peptide SequenceHeavy chain:QIQLQQSG Full view	Length664	Functional ClassificationIIb	DiseaseCancer	BrandAdcetris	CompanySeattle Genetics	Physical AppearanceSterile, white to off-white, preservative-free lyophilized cake or powder in single-use vials.	Route of AdministartionIntravenous infusion	CategoryN.A.	TargetTumor necrosis factor receptor superfamily member 8
ID1628	ThPPIDTh1139	NameCertolizumab Pegol	Peptide SequenceLight chain: DIQMTQS Full view	Length443	Functional ClassificationIIb	DiseaseImmunologcal	BrandCimzia	CompanyUCB	Physical AppearanceSterile, white, lyophilized powder for solution or as a sterile, solution in a single-use prefilled 1 mL glass syringe	Route of AdministartionSubcutaneous injection	CategoryTNF inhibitor	TargetTumor necrosis factor
ID1636	ThPPIDTh1142	NameObinutuzumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIb	DiseaseCancer	BrandGazyva	CompanyGenentech	Physical AppearanceSterile, clear, colorless to slightly brown, preservative free liquid concentrate	Route of AdministartionIntravenous infusion	CategoryAntineoplastic Agents	TargetB-lymphocyte antigen CD20
ID1671	ThPPIDTh1159	NameGemtuzumab ozogamicin	Peptide SequenceLight Chain 1: QIVLT Full view	Length459	Functional ClassificationIIb	DiseaseCancer	BrandMylotarg	CompanyWyeth pharmaceuticals inc	Physical AppearanceSterile, white, preservative-free lyophilized powder	Route of AdministartionIntravenous infusion	CategoryAntineoplastic agents and Immunotoxins	TargetMyeloid cell surface antigen CD33, Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1r subcomponent, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, Complement C1q subcomponent subunit C, Low affinity immunoglobulin gamma Fc region receptor III-A, Complement C1s subcomponent, High affinity immunoglobulin gamma Fc receptor I, Low affinity immunoglobulin gamma Fc region receptor II-a, Low affinity immunoglobulin gamma Fc region receptor II-b, Low affinity immunoglobulin gamma Fc region receptor II-c